20-44414519-G-A

Variant summary

Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2

The NM_175914.5(HNF4A):​c.439G>A​(p.Val147Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000959 in 1,614,194 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00072 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00098 ( 20 hom. )

Consequence

HNF4A
NM_175914.5 missense

Scores

2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:11O:1

Conservation

PhyloP100: 1.24
Variant links:
Genes affected
HNF4A (HGNC:5024): (hepatocyte nuclear factor 4 alpha) The protein encoded by this gene is a nuclear transcription factor which binds DNA as a homodimer. The encoded protein controls the expression of several genes, including hepatocyte nuclear factor 1 alpha, a transcription factor which regulates the expression of several hepatic genes. This gene may play a role in development of the liver, kidney, and intestines. Mutations in this gene have been associated with monogenic autosomal dominant non-insulin-dependent diabetes mellitus type I. Alternative splicing of this gene results in multiple transcript variants encoding several different isoforms. [provided by RefSeq, Apr 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -11 ACMG points.

PM1
In a domain NR LBD (size 230) in uniprot entity HNF4A_HUMAN there are 97 pathogenic changes around while only 8 benign (92%) in NM_175914.5
BP4
Computational evidence support a benign effect (MetaRNN=0.0075802803).
BP6
Variant 20-44414519-G-A is Benign according to our data. Variant chr20-44414519-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 36353.We mark this variant Likely_benign, oryginal submissions are: {not_provided=1, Likely_benign=3, Uncertain_significance=1, Benign=5}. Variant chr20-44414519-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000722 (110/152334) while in subpopulation SAS AF= 0.0141 (68/4830). AF 95% confidence interval is 0.0114. There are 0 homozygotes in gnomad4. There are 62 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 110 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
HNF4ANM_175914.5 linkuse as main transcriptc.439G>A p.Val147Ile missense_variant 5/10 ENST00000316673.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
HNF4AENST00000316673.9 linkuse as main transcriptc.439G>A p.Val147Ile missense_variant 5/101 NM_175914.5 P41235-5

Frequencies

GnomAD3 genomes
AF:
0.000723
AC:
110
AN:
152216
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00288
Gnomad SAS
AF:
0.0141
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000323
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.00201
AC:
505
AN:
251390
Hom.:
6
AF XY:
0.00241
AC XY:
327
AN XY:
135866
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00185
Gnomad SAS exome
AF:
0.0141
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.000202
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000984
AC:
1438
AN:
1461860
Hom.:
20
Cov.:
33
AF XY:
0.00133
AC XY:
968
AN XY:
727226
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.0000671
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00174
Gnomad4 SAS exome
AF:
0.0123
Gnomad4 FIN exome
AF:
0.0000936
Gnomad4 NFE exome
AF:
0.000186
Gnomad4 OTH exome
AF:
0.00141
GnomAD4 genome
AF:
0.000722
AC:
110
AN:
152334
Hom.:
0
Cov.:
32
AF XY:
0.000832
AC XY:
62
AN XY:
74502
show subpopulations
Gnomad4 AFR
AF:
0.0000481
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00289
Gnomad4 SAS
AF:
0.0141
Gnomad4 FIN
AF:
0.000188
Gnomad4 NFE
AF:
0.000323
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.000341
Hom.:
0
Bravo
AF:
0.000366
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00234
AC:
284
Asia WGS
AF:
0.0110
AC:
37
AN:
3478
EpiCase
AF:
0.000382
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:11Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:4
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 18, 2024- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenNov 01, 2023HNF4A: BP4, BS1, BS2 -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Benign, criteria provided, single submitterclinical testingGeneDxFeb 13, 2020This variant is associated with the following publications: (PMID: 32621647, 31216263, 25041077, 27080136, 27535533, 27810688, 15281001, 24097065) -
not specified Benign:3
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsNov 14, 2016- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of ChicagoMay 02, 2019- -
Type 2 diabetes mellitus Uncertain:1Benign:1
Likely benign, criteria provided, single submitterresearchBroad Center for Mendelian Genomics, Broad Institute of MIT and Harvard-The heterozygous p.Val147Ile variant in HNF4A has been identified in 3 Philippino siblings from 1 family with maturity onset diabetes of the young and 2 individuals without diabetes mellitus (PMID: 15281001, 24097065), but has also been identified in >1% of South Asian chromosomes and 4 homozygotes by ExAC (http://gnomad.broadinstitute.org/). Please note that individuals in ExAC may have type II diabetes. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely benign for autosomal dominant diabetes mellitus type 2. -
Uncertain significance, criteria provided, single submitterreference populationSoonchunhyang University Bucheon Hospital, Soonchunhyang University Medical CenterMar 18, 2016- -
Maturity-onset diabetes of the young type 1 Benign:1Other:1
not provided, no classification providedclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpOct 02, 2015- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Familial hyperinsulinism Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Maturity onset diabetes mellitus in young Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsApr 27, 2021This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Uncertain
-0.060
CADD
Benign
14
DANN
Benign
0.91
DEOGEN2
Benign
0.23
.;.;.;T;.;T;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.50
N
LIST_S2
Benign
0.79
T;T;T;T;T;T;T
MetaRNN
Benign
0.0076
T;T;T;T;T;T;T
MetaSVM
Benign
-0.46
T
MutationAssessor
Benign
0.90
.;.;.;.;L;L;L
MutationTaster
Benign
1.0
N;N;N;N;N
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.23
N;.;N;.;N;N;N
REVEL
Uncertain
0.54
Sift
Benign
0.49
T;.;T;.;T;T;T
Sift4G
Benign
0.30
T;T;T;T;T;T;T
Polyphen
0.0010, 0.0
.;B;B;.;B;B;.
Vest4
0.15
MVP
0.97
MPC
0.23
ClinPred
0.0069
T
GERP RS
-3.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.074
gMVP
0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs142204928; hg19: chr20-43043159; COSMIC: COSV105143902; API